Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PFIZER, INC.

(PFE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

CDC Recommends Booster Shots of Pfizer-BioNTech COVID-19 Vaccine for Older Adults, Higher Risk Populations

09/24/2021 | 10:20am EDT


© MT Newswires 2021
All news about PFIZER, INC.
01:05aPFIZER : US marks 200M COVID-19 shots shared with world
AQ
10/20MERCK : British Government Secures COVID-19 Antivirals from Merck & Co., Pfizer
MT
10/20FDA Authorizes Booster Shots for Moderna, J&J Vaccines; Greenlights Mixing Brands
MT
10/20PFIZER : Advisory Committee on Immunization Practices Votes to Recommend Routine Use of Pf..
BU
10/20White House Unveils COVID-19 Vaccine Distribution Plan for Children Ages 5 to 11 Upon A..
MT
10/20U.K. in Agreements for Merck/Ridgeback, Pfizer Covid-19 Antivirals in Development
DJ
10/20FDA OKs mixing COVID vaccines; backs Moderna, J&J boosters
AQ
10/20PFIZER : White House details plans to vaccinate 28M children age 5-11
AQ
10/20CARLYLE : Venture Funds Invest Up to $430 Million in Saama Technologies
MT
10/20Novavax Statement on Initial Com-COV2 Phase 2 Clinical Trial Results Presented at World..
AQ
More news
Analyst Recommendations on PFIZER, INC.
More recommendations
Financials (USD)
Sales 2021 81 510 M - -
Net income 2021 18 627 M - -
Net Debt 2021 29 307 M - -
P/E ratio 2021 12,6x
Yield 2021 3,69%
Capitalization 240 B 240 B -
EV / Sales 2021 3,30x
EV / Sales 2022 3,77x
Nbr of Employees 78 500
Free-Float 59,3%
Chart PFIZER, INC.
Duration : Period :
Pfizer, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PFIZER, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Last Close Price 42,80 $
Average target price 45,72 $
Spread / Average Target 6,83%
EPS Revisions
Managers and Directors
Albert Bourla Chairman, Chief Executive & Operating Officer
Frank A. D'Amelio Chief Financial Officer & EVP-Global Supply
Mikael Dolsten Chief Scientific Officer & Research President
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
Aida Habtezion Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
PFIZER, INC.14.34%239 966
JOHNSON & JOHNSON4.07%431 385
ROCHE HOLDING AG15.84%337 562
NOVO NORDISK A/S57.04%239 813
ELI LILLY AND COMPANY44.35%219 674
MERCK & CO., INC.-2.82%201 219